Cyclin-dependent kinase 6 (CDK6) plays a vital role in regulating the progression of the cell cycle. More recently, CDK6 has also been shown to have a transcriptional role in tumor angiogenesis. Up-regulated CDK6 activity is associated with the development of several types of cancers. While CDK6 is over-expressed in cancer cells, it has a low detectable level in non-cancerous cells and CDK6-null mice develop normally, suggesting a specific oncogenic role of CDK6, and that its inhibition may represent an ideal mechanism-based and low toxic therapeutic strategy in cancer treatment.
Drug targets for cancer: CDK6 research reagents
Other vital drug targets for cancer likeCDK6:
Tadesse S, Yu M, Kumarasiri M, et al. Targeting CDK6 in cancer: State of the art and new insights[J]. Cell Cycle, 2015, 14(20): 3220-3230.